DEF 14A

Company

Protagenic Therapeutics, Inc.\new

Filed

November 6, 2000

Period of Report

November 30, 2000

Accession Number

0000921895-00-000797

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →